📅 2026 Update: Recent Advances in Mesothelioma Treatments

Since the original article was published, significant changes have occurred in the treatment of mesothelioma. The FDA has approved new therapies that may improve survival for patients with this disease. The earlier article continues further down the page.

🧪 FDA Approvals for New Treatments

In September 2024, the FDA approved Keytruda® (pembrolizumab) as a first-line treatment for patients with unresectable advanced or metastatic pleural mesothelioma. This approval was based on the KEYNOTE-483 clinical trial. Patients receiving this combination therapy had a median overall survival of 17.3 months compared to 16.1 months for chemotherapy alone.

In the same year, the FDA also approved the combination of Opdivo® (nivolumab) and Yervoy® (ipilimumab). Patients treated with this combination showed a median overall survival of 18.1 months, compared to 14.1 months for those on chemotherapy alone. These new options represent important advancements in mesothelioma care.

🔍 Updated Treatment Guidelines

The National Comprehensive Cancer Network (NCCN) updated its 2026 guidelines, recommending pleurectomy/decortication (P/D) over extrapleural pneumonectomy (EPP) for pleural mesothelioma. EPP is now reserved for rare cases. The guidelines also no longer include surgery as a treatment option for stage 2 through stage 4 pleural mesothelioma of any cell type.

💰 Costs of New Treatments

The average wholesale price for Keytruda® is approximately $10,000 per 100 mg vial. The total treatment cost will depend on individual patient needs and insurance coverage. Opdivo® costs about $7,000 per 100 mg vial, while Yervoy® is around $1,200 for a 50 mg vial. These costs can vary significantly based on dosage and treatment frequency.

📅 Clinical Trial Participation

Enrollment periods for clinical trials investigating mesothelioma treatments can vary. Patients interested in these trials should discuss options with their healthcare providers. Participating in clinical trials can provide access to cutting-edge therapies that may not yet be widely available.

📌 Key Points

  • Keytruda® and Opdivo®/Yervoy® approved for mesothelioma.
  • NCCN recommends P/D over EPP for surgery.
  • New treatment costs vary and can be high.
  • Clinical trials offer new treatment opportunities.
  • Patients should consult their healthcare providers for options.

💡 Tips for Navigating Mesothelioma Treatment

Reviewing your personal situation with an attorney is essential to understanding your options.

📊 Understand Treatment Options

Familiarize yourself with the latest treatment options. New drugs like Keytruda® and the Opdivo®/Yervoy® combination have shown significant survival benefits. Always discuss these options with your healthcare team.

🏥 Know Your Eligibility

Eligibility for new treatments typically requires patients to be diagnosed with unresectable advanced or metastatic pleural mesothelioma. Discuss your specific situation with your healthcare provider to determine if you qualify.

📆 Keep Track of Clinical Trials

Clinical trial enrollment deadlines vary. If interested in participating, check with your healthcare provider about upcoming trials and their enrollment periods.

💬 Seek Support Resources

Nonprofit organizations like the Mesothelioma Applied Research Foundation provide resources and support for patients. They can help you understand treatment options and connect you with clinical trials.

📊 Follow Up on Treatment Plans

Regular follow-up appointments with your healthcare team are crucial. These visits help assess how well treatments are working and allow for adjustments if needed.

🏆 Free Options Ranked by User Reviews (2026)

No national paid service met the review threshold for this topic. Instead, this section highlights free government and nonprofit resources that can assist patients with mesothelioma.

🥇 1. Mesothelioma Applied Research Foundation

This nonprofit offers resources, support, and information regarding mesothelioma treatments. They provide guidance on accessing clinical trials and understanding available treatment options. Their mission is to improve patient outcomes through education and research.

🥈 2. National Cancer Institute (NCI)

The NCI provides comprehensive information on mesothelioma, including treatment options and clinical trials. They offer resources for patients and families affected by mesothelioma, along with detailed guides on navigating the healthcare system.

🥉 3. Centers for Disease Control and Prevention (CDC)

The CDC offers resources on asbestos exposure and related health risks. Patients can find information on preventing exposure and understanding the health implications of asbestos-related diseases.

4️⃣ American Cancer Society

The American Cancer Society provides a wealth of information about different types of cancer, including mesothelioma. They offer support services, educational materials, and resources for patients and families.

🔎 What to Check Before Paying for Help

  • 💬 Verify the credibility of any organization.
  • 📄 Look for reviews or testimonials from other patients.
  • 🔍 Ensure they provide clear information about services offered.
  • 📞 Check if they have a support hotline for questions.

❓ Frequently Asked Questions

🤔 What is mesothelioma?

Mesothelioma is a type of cancer that affects the lining of the lungs, abdomen, or heart. It is most commonly associated with asbestos exposure and can be difficult to diagnose.

💊 What are the side effects of new mesothelioma treatments?

New treatments like Keytruda® and the Opdivo®/Yervoy® combination can cause side effects such as fatigue, nausea, and immune-related issues. Patients should discuss potential side effects with their healthcare providers.

🏥 Can I receive treatment if I've had previous therapies?

Yes, eligibility for new treatments like Keytruda® and the Opdivo®/Yervoy® combination is typically for patients who have not received prior systemic therapy. Your healthcare provider will assess your situation.

📅 How long do clinical trials usually last?

Clinical trials can vary in duration, often lasting several months to years. The specific timeline depends on the trial's design and goals.

🗓️ Are there any specific eligibility criteria for clinical trials?

Eligibility criteria for clinical trials vary by study. They often include factors such as age, health status, and disease stage. Discuss these criteria with your healthcare provider.

💼 What support is available for patients and families?

Organizations like the Mesothelioma Applied Research Foundation and the American Cancer Society provide resources, support, and information for patients and families affected by mesothelioma.

⚖️ Recent Cases Related to Mesothelioma

Recent court rulings have focused on mesothelioma claims, especially regarding asbestos exposure and liability. These cases can impact how patients pursue compensation and navigate legal challenges.

For more details, you can browse recent rulings on the news page.

End of October 2026 Update






 



What is Mesothelioma Cancer?



 

Clinical Trials


 



Mesothelioma cancer is an uncommon form of cancer that develops from the mutation of cells in the mesothelium—the protective lining that serves as a shield for a number of internal organs of the human body. 



 



 



Mesothelioma cancer is often caused by exposure to asbestos fibers or filaments. The bulk of mesothelioma sufferers typically have worked in jobs where they were in close proximity or direct contact with asbestos. 



 



 



Although there are a number of types, Mesothelioma cancer often forms in the outer lining of the lungs and the internal wall of the chest cavity. Symptoms associated with the disease are: shortness of breath (derived from a build-up of fluid between the lungs and the chest wall), substantial coughing and severe weight loss. 



 



 



In the bulk of cases, diagnosing mesothelioma cancer is exceptionally difficult. The problems tied-into diagnosis stem from the cancer’s slow-developing symptoms--mesothelioma symptoms remain harmless for decades following the initial formation of mesothelioma tumors. 



 



 



Mesothelioma, similar to other cancers, is categorized by stage. As mesothelioma progresses, the outlook becomes more and more pessimistic. The insidious nature of the cancer is attached to the disease’s inconspicuousness to create an extremely deadly disease—most mesothelioma patients die within one year of diagnosis. 



 



 



The brutal outlook associated with mesothelioma derives from an inability to quickly and accurately diagnose the disease. Mesothelioma cancer is rarely identified in its early stages. And when mesothelioma advances to its latter stages the disease becomes inoperable. That being said, there are several mesothelioma treatment options—some palliative and some curative—to either improve the patient’s quality of life or to tangibly extract the cancerous bodies. Moreover, there are several mesothelioma treatment options which are currently in clinical trials. 



 



 



What are Clinical Trials?



 



 



Clinical trials refer to sets of procedures in drug development and medical research that are conducted to promote safety and efficacy for health interventions. Typically, a clinical trial will take place only after substantial information has been gathered on the quality of the drug or treatment initiative. 



 



 



To accurately conduct a clinical trial an investigator will employ health patients or volunteers and place them into small pilot studies. These small groups will be agglomerated after the new drug or product is compared with a traditional or currently prescribed treatment method. As efficacy data amasses, the number of patients will increase to secure an accurate understanding of the drug’s effectiveness. Clinical trials will vary in size from a single center in one jurisdiction to multi-center trials in several countries. 



 



 



Types of Clinical Trials:



 



 



One way of classifying a clinical trial is to control how the researchers behave. For example, an observational study is one where investigators observe the patients/volunteers and measure their outcomes. In this type of clinical trial, the researchers will not actively manage the study.  By contrast, in an interventional study, the investigators five the subjects a specific medication or other product. Typically, the investigators will compare the treated subject to individuals who have received standard treatment or no treatment. Following this comparison, the researchers will then measure how the subject’s health fluctuates or changes. 



 



 



The United States National Institutes of Health organizes trials intro five different categories: 



 



 



Prevention Trials: These types of clinical trials look for more effective ways to prevent disease in individuals who have never had the disease or to prevent the condition from returning. These approaches will often include: vitamins, vaccines, lifestyle changes, minerals and medicines. 



 



 



Screening Trials: These types of clinical trials will test the most efficient way to detect a health condition or certain disease. 



 



 



Diagnostic Trials: These clinical trials are conducted to find more effective procedures or tests for diagnosing particular cancers or diseases. 



 



 



Treatment Trials: These clinical trials test experimental treatments, new approaches to therapy or surgery and new combinations of drugs. 



 



 



Quality of Life Trials: Appropriately named, a quality of life trial will explore ways to improve a patient’s comfort and the quality of life for those with chronic diseases.



 



 



Expanded Access Trials: These clinical trials provide partially tested and unapproved therapeutics before a small number of test subjects that have no other realistic treatment options. Typically this clinical trial type will involve a disease for which no effective treatment course exists or for those patients who have already attempted and failed standard treatments. An expanded access trial may also be undertaken for those patients whose health is so fragile that he/she does not qualify for participation in anonymous clinical trials. Frequently, case by case approval has to be granted by the pharmaceutical company responsible for creating the drug and the FDA.